Jinhua Bayford-Xu
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency.
Journal: The New England journal of medicine
Published: October 15, 2025
Safety and Diagnostic Utility of Brain Biopsy and Metagenomics in Decision-Making for Patients with Inborn Errors of Immunity (IEI) and Unexplained Neurological Manifestations.
Journal: Journal of clinical immunology
Published: June 24, 2024
Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity.
Journal: Journal of clinical immunology
Published: October 17, 2022
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
Journal: The New England journal of medicine
Published: May 11, 2021
Severe Combined Immunodeficiency (SCID)-the Irish Experience.
Journal: Journal of clinical immunology
Published: April 10, 2021
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
Journal: JAMA
Published: April 22, 2015
Spectrum of mutations in a cohort of UK patients with ADA deficient SCID: Segregation of genotypes with specific ethnicities.
Journal: Clinical immunology (Orlando, Fla.)
Published: February 20, 2015
A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.
Journal: The New England journal of medicine
Published: October 09, 2014
Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency.
Journal: Journal of clinical immunology
Published: November 21, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026